| Ytd | 0.61% | |
| 1y | 17.60% |
| Open | 23.15 | Prev Close | 23.19 | Low | 22.96 | High | 23.82 | Mkt Cap | 41.39M |
| Vol | 22.20K | Avg Vol | 127.60K | EPS | -0.64 | P/E | N/A | Forward P/E | 13.34 |
| Beta | 1.42 | Short Ratio | 0.59 | Inst. Own | 8.79% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 25.47 | 200-d Avg | 25.23 | 1yr Est | 19.00 |
PRPO News
Precipio, Inc. (NASDAQ: PRPO - Get Free Report)'s share price passed below its two hundred day movin
Precipio and Fulgent Genetics differ in business scope, valuation and growth drivers, but which canc
AdaptHealth (NASDAQ: AHCO - Get Free Report) and Precipio (NASDAQ: PRPO - Get Free Report) are both
Precipio (NASDAQ:PRPO) held its second-quarter earnings conference call on Monday. Below is the comp
Precipio and Biodesix take different approaches to cancer diagnostics, but which stock looks more co
PRPO's second-quarter 2026 revenue momentum strengthens on higher diagnostic volumes and record prod
Precipio, Inc. (PRPO) Q2 2026 Earnings Call Transcript
Precipio (NASDAQ:PRPO) reported quarterly losses of $(0.12) per share. This is a 340 percent decreas
Revenue reaches quarterly record as Precipio returns to positive Adjusted EBITDA and strengthens cas
Precipio, Inc. (NASDAQ: PRPO - Get Free Report) passed below its 200-day moving average during tradi
NEW HAVEN, Conn., July 31, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, I
Precipio and NeoGenomics take different approaches to cancer diagnostics, but which oncology stock l
NEW HAVEN, Conn., June 12, 2026 (GLOBE NEWSWIRE) -- Management of specialty cancer diagnostics compa
NEW HAVEN, Conn., June 11, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio,
PRPO's first-quarter 2026 sales are driven by pathology momentum, but CMS reimbursement cuts and hig
Precipio, Inc. (PRPO) Q1 2026 Earnings Call Transcript
Precipio (NASDAQ:PRPO) reported quarterly losses of $(0.81) per share. This is a 37.29 percent decre
Stable revenue performance driven by timing dynamics; expanding product pipeline expected to drive s
NEW HAVEN, Conn. , May 13, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, I
AI demand and pipeline growth headline top Zacks stock reports on NVIDIA, Mastercard and AbbVie.
NEW HAVEN, Conn. , May 06, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, I
Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), announces some preliminary (unaud
Precipio (NASDAQ:PRPO) reported quarterly earnings of $0.05 per share. This is a 106.02 percent incr
Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO) has entered into an agreement with
During the session on Thursday, 461 stocks hit new 52-week lows.
Monday's session saw 175 companies set new 52-week lows.
Friday's session saw 59 companies set new 52-week lows.
Friday's session saw 32 companies set new 52-week lows.
During Thursday, 35 stocks hit new 52-week lows.
On Friday, 127 companies set new 52-week lows.
Gainers Helius Medical Technologies, Inc. (NASDAQ: HSDT) shares jumped 167% to $1.72 after droppi
On Friday, 1043 companies hit new 52-week lows.
During Tuesday, 581 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week
On Friday, 431 companies hit new 52-week lows.
On Tuesday, 242 companies hit new 52-week lows.
Gainers Inspirato Incorporated (NASDAQ: ISPO) shares surged 50.5% to close at $54.90.
During Wednesday's morning trading, 400 companies set new 52-week lows.
On Thursday, 615 stocks hit new 52-week lows.
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is estimated to report earnings for
Gainers Vinco Ventures, Inc. (NASDAQ: BBIG) shares rose 80.9% to close at $5.30 on Friday. The co